Similar articles for PMID: 32414949

Year	Number of Results
1999	1
2000	1
2001	1
2002	6
2003	1
2004	3
2005	5
2006	4
2007	6
2008	6
2009	7
2010	9
2011	7
2012	12
2013	6
2014	17
2015	7
2016	9
2017	13
2018	11
2019	20
2020	45
2021	58
2022	52
2023	27
2024	0

1

Peptide Receptor Radionuclide Therapy with ⁶⁷Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor Model.

Cullinane C, Jeffery CM, Roselt PD, van Dam EM, Jackson S, Kuan K, Jackson P, Binns D, van Zuylekom J, Harris MJ, Hicks RJ, Donnelly PS. Cullinane C, et al. J Nucl Med. 2020 Dec;61(12):1800-1805. doi: 10.2967/jnumed.120.243543. Epub 2020 May 15. J Nucl Med. 2020. PMID: 32414949 Free article.

2

PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate.

Paterson BM, Roselt P, Denoyer D, Cullinane C, Binns D, Noonan W, Jeffery CM, Price RI, White JM, Hicks RJ, Donnelly PS. Paterson BM, et al. Dalton Trans. 2014 Jan 21;43(3):1386-96. doi: 10.1039/c3dt52647j. Epub 2013 Nov 7. Dalton Trans. 2014. PMID: 24202174

3

Comparison of the Therapeutic Response to Treatment with a 177Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical Models.

Dalm SU, Nonnekens J, Doeswijk GN, de Blois E, van Gent DC, Konijnenberg MW, de Jong M. Dalm SU, et al. J Nucl Med. 2016 Feb;57(2):260-5. doi: 10.2967/jnumed.115.167007. Epub 2015 Oct 29. J Nucl Med. 2016. PMID: 26514177 Free article.

4

Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog ¹⁷⁷Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors.

Zhang J, Wang H, Jacobson O, Cheng Y, Niu G, Li F, Bai C, Zhu Z, Chen X. Zhang J, et al. J Nucl Med. 2018 Nov;59(11):1699-1705. doi: 10.2967/jnumed.118.209841. Epub 2018 Apr 13. J Nucl Med. 2018. PMID: 29653971 Free PMC article. Clinical Trial.

5

Enhancing the anti-tumour activity of ¹⁷⁷Lu-DOTA-octreotate radionuclide therapy in somatostatin receptor-2 expressing tumour models by targeting PARP.

Cullinane C, Waldeck K, Kirby L, Rogers BE, Eu P, Tothill RW, Hicks RJ. Cullinane C, et al. Sci Rep. 2020 Jun 23;10(1):10196. doi: 10.1038/s41598-020-67199-9. Sci Rep. 2020. PMID: 32576907 Free PMC article.

6

Multimodal Imaging of 2-Cycle PRRT with ¹⁷⁷Lu-DOTA-JR11 and ¹⁷⁷Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model.

Albrecht J, Exner S, Grötzinger C, Prasad S, Konietschke F, Beindorff N, Kühl AA, Prasad V, Brenner W, Koziolek EJ. Albrecht J, et al. J Nucl Med. 2021 Mar;62(3):393-398. doi: 10.2967/jnumed.120.250274. Epub 2020 Aug 28. J Nucl Med. 2021. PMID: 32859703 Free PMC article.

7

⁶⁴Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy.

Hicks RJ, Jackson P, Kong G, Ware RE, Hofman MS, Pattison DA, Akhurst TA, Drummond E, Roselt P, Callahan J, Price R, Jeffery CM, Hong E, Noonan W, Herschtal A, Hicks LJ, Hedt A, Harris M, Paterson BM, Donnelly PS. Hicks RJ, et al. J Nucl Med. 2019 Jun;60(6):777-785. doi: 10.2967/jnumed.118.217745. Epub 2018 Nov 15. J Nucl Med. 2019. PMID: 30442752 Free PMC article. Clinical Trial.

8

Tumor imaging and therapy using radiolabeled somatostatin analogues.

de Jong M, Breeman WA, Kwekkeboom DJ, Valkema R, Krenning EP. de Jong M, et al. Acc Chem Res. 2009 Jul 21;42(7):873-80. doi: 10.1021/ar800188e. Acc Chem Res. 2009. PMID: 19445476

9

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.

Kwekkeboom DJ, Kam BL, van Essen M, Teunissen JJ, van Eijck CH, Valkema R, de Jong M, de Herder WW, Krenning EP. Kwekkeboom DJ, et al. Endocr Relat Cancer. 2010 Jan 29;17(1):R53-73. doi: 10.1677/ERC-09-0078. Print 2010 Mar. Endocr Relat Cancer. 2010. PMID: 19995807 Review.

10

Hedgehog inhibitor sonidegib potentiates ¹⁷⁷Lu-octreotate therapy of GOT1 human small intestine neuroendocrine tumors in nude mice.

Spetz J, Langen B, Rudqvist N, Parris TZ, Helou K, Nilsson O, Forssell-Aronsson E. Spetz J, et al. BMC Cancer. 2017 Aug 8;17(1):528. doi: 10.1186/s12885-017-3524-x. BMC Cancer. 2017. PMID: 28789624 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

287 results

Results by year